152 related articles for article (PubMed ID: 35740612)
1. Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results.
Kutuk T; Tolakanahalli R; McAllister NC; Hall MD; Tom MC; Rubens M; Appel H; Gutierrez AN; Odia Y; Mohler A; Ahluwalia MS; Mehta MP; Kotecha R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740612
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
[TBL] [Abstract][Full Text] [Related]
3. Wide-field pulsed reduced dose rate radiotherapy (PRDR) for recurrent ependymoma in pediatric and young adult patients.
Mohindra P; Robins HI; Tomé WA; Hayes L; Howard SP
Anticancer Res; 2013 Jun; 33(6):2611-8. PubMed ID: 23749916
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
Megahed R; Prabhu AV; Mack DP; Gholami S; Samanta S; Patel M; Lewis GD
Oral Oncol; 2024 May; 152():106778. PubMed ID: 38555751
[TBL] [Abstract][Full Text] [Related]
5. Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas.
Harari CM; Burr AR; Morris BA; Tomé WA; Bayliss A; Bhatia A; Grogan PT; Robins HI; Howard SP
Neurooncol Adv; 2024; 6(1):vdae073. PubMed ID: 38845694
[TBL] [Abstract][Full Text] [Related]
6. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy.
Witt JS; Musunuru HB; Bayliss RA; Howard SP
J Neurooncol; 2019 Jan; 141(1):103-109. PubMed ID: 30392090
[TBL] [Abstract][Full Text] [Related]
7. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
[TBL] [Abstract][Full Text] [Related]
8. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
[TBL] [Abstract][Full Text] [Related]
9. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.
Bovi JA; Prah MA; Retzlaff AA; Schmainda KM; Connelly JM; Rand SD; Marszalkowski CS; Mueller WM; Siker ML; Schultz CJ
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):979-986. PubMed ID: 32599030
[TBL] [Abstract][Full Text] [Related]
10. Pulsed Reduced Dose Rate for Reirradiation of Recurrent Breast Cancer.
Burr AR; Robins HI; Bayliss RA; Howard SP
Pract Radiat Oncol; 2020; 10(2):e61-e70. PubMed ID: 31526900
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
12. Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy.
Burr AR; Robins HI; Bayliss RA; Baschnagel AM; Welsh JS; Tomé WA; Howard SP
Adv Radiat Oncol; 2020; 5(5):834-839. PubMed ID: 33083645
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.
Ryg U; Seierstad T; Nilsen LB; Hellebust TP; Djupvik LH; Gustafson H; Hydal J; Kishan AU; Hole KH; Lilleby W
Front Oncol; 2022; 12():861127. PubMed ID: 35463376
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
[TBL] [Abstract][Full Text] [Related]
15. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation for recurrent primary central nervous system tumors: Eight-year audit from a tertiary cancer care center in South India.
Menon D; Chelakkot PG
Indian J Cancer; 2017; 54(2):409-414. PubMed ID: 29469068
[TBL] [Abstract][Full Text] [Related]
17. Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
Grambozov B; Nussdorfer E; Kaiser J; Gerum S; Fastner G; Stana M; Gaisberger C; Wass R; Studnicka M; Sedlmayer F; Zehentmayr F
Curr Oncol; 2021 May; 28(3):1835-1846. PubMed ID: 34068043
[TBL] [Abstract][Full Text] [Related]
18. Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine.
Prabhu AV; Lee M; Galhardo E; Newkirk M; Rodriguez A; Xia F
Surg Neurol Int; 2021; 12():280. PubMed ID: 34221611
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation.
Ehret F; Wolfgang J; Allwohn L; Onken J; Wasilewski D; Roohani S; Oertel J; Zips D; Kaul D
Clin Transl Radiat Oncol; 2023 Sep; 42():100653. PubMed ID: 37502699
[TBL] [Abstract][Full Text] [Related]
20. Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff.
Held T; Harrabi SB; Lang K; Akbaba S; Windisch P; Bernhardt D; Rieken S; Herfarth K; Debus J; Adeberg S
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
